[Mumps--still actual epidemiological problem in Poland]
Links [Mumps--still actual epidemiological problem in Poland] [Article in Polish] Pogorzelska M, Oldak E, Sulik APrzegl Epidemiol. 2005;59(4):841-9. Links [Mumps--still actual epidemiological problem in Poland] [Article in Polish] Pogorzelska M, Oldak E, Sulik A. Klinika Obserwacyjno-Zakazna Dzieci Akademii Medycznej w Bialymstoku. kloz@amb.edu.pl Mumps is a viral infection primarily affecting the salivary glands. Although disease is usually mild about 10-15% of patients can develop aseptic meningitis. Rare but more serious complication is encephalitis, which can result in death. Orchitis, pancreatitis, deafness are other complications of mumps. In the countries where there is no vaccination for mumps, its incidence remains high, usually 100 per 100,000 population with epidemic peaks every 2-5 years. Peak incidence is found among children 5-9 years of age. The mumps morbidity in Poland is in the range 50-560 per 100,000 population. Up to 2003, 107 countries reported using mumps vaccine in their national immunization programmes. Countries that have achieved high coverage have shown rapid decline in mumps morbidity (for a one-dose schedule or = 80%, for two-dose schedule or = 97%). This review analyses the clinical manifestation, epidemiology of mumps as well as immunogenicity, effectiveness and safety of different types of mumps vaccines. It also provides information about epidemiological situation for mumps in Poland in the context of national mumps immunization programmme. There is low seroprevalence among the children population in Poland--up to 2003, about 75% children population in the 1 to 4 age group was seronegative for mumps. The childhood mumps vaccination should aim at an 80% coverage rate, or more. An insufficient childhood vaccination coverage may result in an epidemiological shift in the incidence of mumps to older age groups. If a large proportion of the population remains seronegative for mumps, vaccination of adults should be also considered. PMID: 16729425 [PubMed - indexed for MEDLINE] Related Links [Mumps in Poland in 2003] [Przegl Epidemiol. 2005] PMID: 16190522 [Mumps in Poland in 2001] [Przegl Epidemiol. 2003] PMID: 12926308 [Wide spread inflammation of the parotid glands (mumps): underestimated disease. I. Epidemiology of the mumps and its medical meaning in Poland] [Przegl Epidemiol. 1998] PMID: 10321083 [Mumps in Poland in 2002] [Przegl Epidemiol. 2004] PMID: 15218641 Mumps and mumps vaccine: a global review. [Bull World Health Organ. 1999] PMID: 10063655 See all Related Articles... Display Summary Brief Abstract AbstractPlus Citation MEDLINE XML UI List LinkOut ASN.1 Related Articles Cited Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Gene (GeneRIF) Links Genome Links Project Links GENSAT Links GEO Profile Links HomoloGene Links Nucleotide Links Nucleotide (RefSeq) Links OMIA Links OMIM (calculated) Links OMIM (cited) Links BioAssay Links Compound Links Compound via MeSH Substance Links Substance via MeSH PMC Links Cited in PMC PopSet Links Probe Links Protein Links Protein (RefSeq) Links SNP Links Structure Links Taxonomy via GenBank UniGene Links UniSTS Links Show 5 10 20 50 100 200 500 Sort by Pub Date First Author Last Author Journal Send to Text File Printer Clipboard E-mail Order .
Klinika Obserwacyjno-Zakazna Dzieci Akademii Medycznej w Bialymstoku. kloz@amb.edu.pl
Mumps is a viral infection primarily affecting the salivary glands. Although disease is usually mild about 10-15% of patients can develop aseptic meningitis. Rare but more serious complication is encephalitis, which can result in death. Orchitis, pancreatitis, deafness are other complications of mumps. In the countries where there is no vaccination for mumps, its incidence remains high, usually >100 per 100,000 population with epidemic peaks every 2-5 years. Peak incidence is found among children 5-9 years of age. The mumps morbidity in Poland is in the range 50-560 per 100,000 population. Up to 2003, 107 countries reported using mumps vaccine in their national immunization programmes. Countries that have achieved high coverage have shown rapid decline in mumps morbidity (for a one-dose schedule > or = 80%, for two-dose schedule > or = 97%). This review analyses the clinical manifestation, epidemiology of mumps as well as immunogenicity, effectiveness and safety of different types of mumps vaccines. It also provides information about epidemiological situation for mumps in Poland in the context of national mumps immunization programmme. There is low seroprevalence among the children population in Poland--up to 2003, about 75% children population in the 1 to 4 age group was seronegative for mumps. The childhood mumps vaccination should aim at an 80% coverage rate, or more. An insufficient childhood vaccination coverage may result in an epidemiological shift in the incidence of mumps to older age groups. If a large proportion of the population remains seronegative for mumps, vaccination of adults should be also considered.
This abstract is being posted for educational purposes, as well as for comment and criticism, by the visitors to the Epididymitis Foundation website (www.EpididymitisFoundation.org). This abstract is representative of a larger article that is indexed on Medline.
Men's Health Web Ring
SurvivingProstateCancerWithoutSurgery.org
VasectomyFoundation.org
Prostatitis Foundation
( Prostatitis.org)
Disclaimer: Information provided on this web site is for educatonal purposes only. It is not a substitute for, nor can it replace advice from your own physician. The information on this site is not to be used for diagnosing or treating any health concerns that you may have. Testicular torsion, which is a medical emergency can be confused with epididymitis. You must see your own physician for diagnosis and treatment. Furthermore, the information on this site is never guaranteed to be 100% accurate or 100% up to date. All the side effects of mentioned treatments, drugs, surgeries, or therapies cannot always be listed or be known. Errors and omissions may occur in any essay. See a competent physician for your health care needs.
EpididymitisFoundation.org™ Established December 11, 2002
